DaVita Inc.

DVA ·Healthcare, Medical Care Facilities, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $13.64B $12.82B $12.14B $11.61B $11.62B $11.55B $11.39B $11.40B
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $1.67B $1.54B $1.47B $1.36B $1.20B $1.25B $1.10B $1.14B
Operating Income $2.04B $2.09B $1.60B $1.34B $1.80B $1.69B $1.64B $1.53B
Operating Margin 15.0% 16.3% 13.2% 11.5% 15.5% 14.7% 14.4% 13.4%
Interest Expense $539.9M $435.2M $374.0M $339.2M $267.0M $282.9M $419.6M $461.9M
Pretax Income $1.35B $1.53B $1.18B $966.3M $1.52B $1.32B $1.20B $1.05B
Income Tax Expense $293.1M $279.7M $220.1M $198.1M $306.7M $313.9M $279.6M $258.4M
Net Income $746.8M $936.3M $691.5M $560.4M $978.5M $773.6M $811.0M $159.4M
Net Margin 5.5% 7.3% 5.7% 4.8% 8.4% 6.7% 7.1% 1.4%
EPS (Basic) $10.06 $11.02 $7.62 $6.03 $9.30 $6.46 $5.29 $0.93
EPS (Diluted) $9.84 $10.73 $7.42 $5.85 $8.90 $6.31 $5.27 $0.92
Shares Outstanding (Basic) 74.2M 85.0M 90.8M 93.0M 105.2M 119.8M 153.2M 170.8M
Shares Outstanding (Diluted) 75.9M 87.3M 93.2M 95.8M 109.9M 122.6M 153.8M 172.4M
Dividends Per Share
← Newer Page 1 of 2 Older →